By Route of Administration

Subcutaneous (Auto-Injector / Prefilled Syringe) Market Analysis

Cross-industry research covering Subcutaneous (Auto-Injector / Prefilled Syringe) across 1 market reportspanning Pharmaceuticals & Medical Devices — Ophthalmic Surgery.

1 Reports

1 Industries

Reports Covering Subcutaneous (Auto-Injector / Prefilled Syringe)

Oculoplastic Surgery Market to Reach USD 8.4 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Medical Devices — Ophthalmic Surgery·Market: USD 4.8 Billion (2025)·CAGR: 7.2%

The fastest-growing administration route, driven by next-generation anti-IGF-1R programs from Viridian (VRDN-003) and Tourmaline Bio (TOUR006, NCT06088979); subcutaneous formulations shift reimbursement from Medicare Part B to Part D or commercial pharmacy benefit, altering gross-to-net dynamics and PBM leverage substantially.

12%

Market Share

21.3%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments